ArticleAdvances in therapy2019

Survival, Motor Function, and Motor Milestones: Comparison of AVXS-101 Relative to Nusinersen for the Treatment of Infants with Spinal Muscular Atrophy Type 1.

Omar Dabbous et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.